Reading Time: 2 minutes Reuters – A U.S. judge on Monday affirmed a verdict against Bayer AG unit Monsanto that found its glyphosate-based weed-killers responsible for a man’s terminal cancer, sending the German company’s shares down 8 percent. In a ruling by San Francisco’s Superior Court of California, Judge Suzanne Bolanos said she would slash the punitive damages award […] Read more
U.S. judge affirms Monsanto weed-killer verdict, slashes damages
Bayer likely to get new trial in glyphosate case
Reading Time: 2 minutes San Francisco | Reuters — Bayer’s Monsanto unit was likely to get a new trial on the US$250 million in punitive damages awarded by a jury to a groundskeeper who alleged the company’s glyphosate-based herbicides, including Roundup, caused his cancer. According to a Wednesday court filing in San Francisco’s Superior Court of California, Judge Suzanne […] Read more
Ag trade flows may change amid trade dispute, Bayer says
Reading Time: 2 minutes Monheim | Reuters — Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities. The head of Bayer’s crop science division told Reuters his company could even benefit if U.S. farmers switched […] Read more
With drugs pipeline in focus, Bayer seen considering cuts
Reading Time: 3 minutes Frankfurt | Reuters — Bayer is considering job cuts and outsourcing as part of a wide-ranging review of drug research and development that will last until at least November, a person familiar with the company told Reuters. The prospect of “very tangible changes” contributed to a decision by key board members to extend the contract […] Read more
Brazilian court overturns ban on glyphosate
Reading Time: 2 minutes Brasilia | Reuters — A Brazilian court on Monday overturned an injunction banning products containing the herbicide glyphosate, knocking down a previous ruling that had been set to disrupt the soy planting season set to begin this month. A Brazilian judge ruled last month to halt the registration of new glyphosate-based products in the country […] Read more
Roundup cancer verdict sends Bayer shares sliding
Reading Time: 3 minutes Frankfurt | Reuters — Bayer shares plunged as much as 14 per cent on Monday, losing about US$14 billion in value, after newly acquired Monsanto was ordered to pay US$289 million in damages in the first of possibly thousands of U.S. lawsuits over alleged links between a weedkiller and cancer. After the verdict […] Read more
Glyphosate maker Monsanto ruled liable in U.S. cancer trial
Reading Time: 2 minutes Reuters — A California jury on Friday found Monsanto liable in a lawsuit filed by a man who alleged the company’s glyphosate-based herbicides, including Roundup, caused his cancer and ordered the company to pay US$289 million in damages. The case of school groundskeeper Dewayne Johnson was the first lawsuit to go to trial alleging glyphosate […] Read more
U.S. judge allows Roundup-related suits to go to trial
Reading Time: 2 minutes Reuters — Hundreds of lawsuits against Monsanto Co. by cancer survivors or families of those who died can proceed to trial, a federal judge ruled on Tuesday, finding there was sufficient evidence for a jury to hear the cases that blame the company’s glyphosate herbicide for the disease. The decision by U.S. District Judge Vince […] Read more
Brazil judge orders Monsanto to deposit royalties related to GMO seed
Reading Time: 2 minutes Sao Paulo | Reuters — A Brazilian judge has ordered local units of Monsanto to put royalties related to a GMO soy seed technology in an escrow account, in a decision likely to hinder the U.S. seed company’s ability to collect royalties from the business. The July 3 ruling relates to a patent dispute between […] Read more
With deal to close this week, Bayer to retire Monsanto name
Reading Time: 2 minutes Frankfurt | Reuters — Germany’s Bayer will wrap up the US$63 billion takeover of Monsanto on Thursday and also retire the U.S. seed and chemical firm’s 117-year-old name. The German drugmaker had received all required approvals from regulatory authorities, it said in a statement on Monday. “Bayer will remain the company name. Monsanto will no […] Read more
A message from April Stewart, Country Guide's Associate Editor
